Decrease of renal function in HCV and HIV/HCV-infected patients with telaprevir-based therapy.
aInfectious Disease Clinic, AOU IRCCS San Martino-IST, Genoa bDepartment of Infectious Diseases, L. Sacco Hospital, Milan cUnit of Infectious Diseases, Busto Arsizio Hospital, Busto Arsizio dInfectious Disease Division, Policlinico, Modena eInfectious Disease Clinic, University of Bari, Bari fInfectious Disease Unit, AOU Careggi, Firenze gDepartment of Infectious Diseases, Pescara Hospital, Pescara hUnit of Infectious Diseases, A. Manzoni Hospital, Lecco, Italy.
Roberta
R
Prinapori
Elena
E
Ricci
Barbara
B
Menzaghi
Vanni
V
Borghi
Paolo
P
Maggi
Canio
C
Martinelli
Carlo
C
Magni
Giustino
G
Parruti
Paolo
P
Bonfanti
Cristina
C
Mussini
Antonio
A
Di Biagio
D060085:Coinfection / Q000188:drug therapy*; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000009:adverse effects* / Q000627:therapeutic use*
D009842:Oligopeptides